Work plan

EFFECTS has recruited its target, e.g. 1,500 patients, as of 28 June 2019.

Work plan with milestones

Figure 1 below illustrates some of the important milestones for EFFECTS. This is how we want to achieve our goals.

  • Last patient in March 2019 (ideally) or July 2019 (probably)
  • Compiling the database: From 2018 to 2020
  • Publications: Our preliminary plan is to present the main results at the European Stroke Organization Congress (ESOC) World Stroke Conference (WSC). In 2020 these two congresses will be merged into one in Vienna, Austria.
  • Pooling data for our two sister trials: 2020-2022
  • Planning and writing subgroup analysis: 2019-2023
Figure 1. Milestones for EFFECTS. The green arrow Last-patient in 35 denotes the inclusion rate of 35 pat/months with Last follow-up 35 one year later. Update of EFFECTS denotes a planned article for the whole cohort, not breaking the code

 

Economics

EFFECTS has received substantial economic support, totalling 36 006 500 SEK. The Swedish Research Council (Vetenskapsrådet, VR) has granted us 31 114 000 SEK, the largest ever grant from VR for a clinical study in Sweden. We currently have tenancies of VR funds up to the end of 2020, meaning that EFFECTS has stable finances.